A Food and Drug Administration (FDA) advisory committee has voted 11 to 2 against a recommendation that the agency approve a long-studied antiarrhythmic agent for cardioversion of recent-onset atrial ...

Pharmacologic cardioversion followed by electrical cardioversion and electrical cardioversion only were found to be safe and effective in patients presenting to the emergency department with recent ...

ROME, ITALY — Using the factor Xa inhibitor edoxaban (Savaysa/Lixiana, Daiichi Sankyo) to anticoagulate patients about to undergo electrical cardioversion for their atrial fibrillation (AF) seems ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

Left atrial (LA) thrombus is not infrequently found in patients with atrial fibrillation (AF) or flutter who have been taking oral anticoagulation continuously for at least 3 weeks, a meta-analysis ...

Sinus rhythm was restored in an effective, safe and rapid manner using drug-shock or shock-only strategies among patients in the ED with acute atrial fibrillation, according to results of the RAFF-2 ...

The 204 people randomized to IV procainamide (plus electrical cardioversion if necessary, with up to three shocks) showed a 96% rate of conversion to sinus rhythm that was maintained for at least 30 ...

The first step to manage your atrial fibrillation (AFib) is to talk to your doctor about treatments that will control your heart rate or heart rhythm. One way to control your AFib is to take rhythm ...

Citing safety concerns, the Cardiovascular and Renal Drug Advisory Committee of the FDA voted 2-11 against approval of vernakalant for the rapid conversion of recent-onset atrial fibrillation. The ...